Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1910 1
1930 1
1932 1
1933 1
1941 2
1942 1
1945 7
1946 21
1947 14
1948 22
1949 13
1950 15
1951 7
1952 19
1953 30
1954 36
1955 22
1956 24
1957 32
1958 34
1959 44
1960 46
1961 42
1962 55
1963 87
1964 92
1965 43
1966 49
1967 48
1968 65
1969 92
1970 78
1971 92
1972 82
1973 124
1974 101
1975 138
1976 234
1977 156
1978 182
1979 174
1980 137
1981 123
1982 172
1983 189
1984 245
1985 248
1986 267
1987 314
1988 346
1989 324
1990 384
1991 419
1992 478
1993 510
1994 597
1995 680
1996 738
1997 721
1998 842
1999 999
2000 1127
2001 1227
2002 1313
2003 1511
2004 1717
2005 2036
2006 2355
2007 2367
2008 2576
2009 3177
2010 3528
2011 3759
2012 3547
2013 3735
2014 3953
2015 3977
2016 3939
2017 3995
2018 4246
2019 4294
2020 5418
2021 6614
2022 6447
2023 5385
2024 1619

Text availability

Article attribute

Article type

Publication date

Search Results

87,166 results

Results by year

Filters applied: . Clear all
Page 1
Human vaccines & immunotherapeutics.
Ellis RW. Ellis RW. Hum Vaccin. 2011 Oct;7(10):994. doi: 10.4161/hv.7.10.18260. Hum Vaccin. 2011. PMID: 22134395 No abstract available.
Plant-based vaccines for potential human application: a review.
Gómez E, Zoth SC, Berinstein A. Gómez E, et al. Hum Vaccin. 2009 Nov;5(11):738-44. doi: 10.4161/hv.5.11.9879. Epub 2009 Nov 23. Hum Vaccin. 2009. PMID: 19829054 Review.
The worldwide need to produce safe and affordable vaccines with a minimum requirement of manufacture and processing, together with the advancements achieved in biotechnology, have promoted the development of efficient alternatives to traditional ones. ...Thus, the hypothes …
The worldwide need to produce safe and affordable vaccines with a minimum requirement of manufacture and processing, together with th …
Vaccines against viral hemorrhagic fevers: non-human primate models.
Carrion R Jr, Patterson JL. Carrion R Jr, et al. Hum Vaccin. 2011 Jun;7(6):667-73. doi: 10.4161/hv.7.6.14981. Epub 2011 Jun 1. Hum Vaccin. 2011. PMID: 21445006 Review.
The sporadic nature of disease outbreaks and the ethical issues associated with conducting a human trial for such diseases make human studies impractical; therefore, development of countermeasures must occur in relevant animal models. ...This review article summariz …
The sporadic nature of disease outbreaks and the ethical issues associated with conducting a human trial for such diseases make hu …
Filovirus vaccines.
Bradfute SB, Dye JM Jr, Bavari S. Bradfute SB, et al. Hum Vaccin. 2011 Jun;7(6):701-11. doi: 10.4161/hv.7.6.15398. Epub 2011 Jun 1. Hum Vaccin. 2011. PMID: 21519188 Free PMC article. Review.
Filoviruses can cause severe and often fatal hemorrhagic fever in humans and non-human primates (NHPs). Although there are currently no clinically proven treatments for filovirus disease, much progress has been made in recent years in the discovery of therapeutics and v …
Filoviruses can cause severe and often fatal hemorrhagic fever in humans and non-human primates (NHPs). Although there are currently …
Development of active and passive human vaccines to treat methamphetamine addiction.
Gentry WB, Rüedi-Bettschen D, Owens SM. Gentry WB, et al. Hum Vaccin. 2009 Apr;5(4):206-13. doi: 10.4161/hv.5.4.7456. Epub 2009 Apr 20. Hum Vaccin. 2009. PMID: 19276653 Free PMC article. Review.
To meet this challenge, a new generation of passive monoclonal antibodies and active immunization therapies are at an advanced stage of preclinical development. Both of these vaccines could play an essential role in a well planned recovery program from human METH ad …
To meet this challenge, a new generation of passive monoclonal antibodies and active immunization therapies are at an advanced stage of prec …
Meningococcal glycoconjugate vaccines.
Gasparini R, Panatto D. Gasparini R, et al. Hum Vaccin. 2011 Feb;7(2):170-82. doi: 10.4161/hv.7.2.13717. Epub 2011 Feb 1. Hum Vaccin. 2011. PMID: 21178398 Free PMC article. Review.
For this reason, efforts to control the disease have been directed at optimizing meningococcal vaccines and implementing appropriate vaccination policies. In the past, plain polysaccharide vaccines containing purified capsular polysaccharides A, C, Y and W135 were d …
For this reason, efforts to control the disease have been directed at optimizing meningococcal vaccines and implementing appropriate …
Vaccines and vaccination strategies against human cutaneous leishmaniasis.
Okwor I, Uzonna J. Okwor I, et al. Hum Vaccin. 2009 May;5(5):291-301. doi: 10.4161/hv.5.5.7607. Epub 2009 May 12. Hum Vaccin. 2009. PMID: 19221514 Review.
Although vaccination in murine studies has yielded promising results, these vaccines have failed miserably when tested in primates or humans. The reasons behind these failures are unknown and remain a major hurdle for vaccine design and development against cutaneous leishm …
Although vaccination in murine studies has yielded promising results, these vaccines have failed miserably when tested in primates or …
Sex differences in injection site reactions with human vaccines.
Cook IF. Cook IF. Hum Vaccin. 2009 Jul;5(7):441-9. doi: 10.4161/hv.8476. Epub 2009 Jul 18. Hum Vaccin. 2009. PMID: 19377279 Review.
In accord with the well documented greater pain sensitivity in females compared with males, in all studies with vaccines which reported pain during and post vaccination [hepatitis A, B, diphtheria/tetanus toxoid, diphtheria/tetanus/pertussis(DTaP and Tdap), anthrax and ina …
In accord with the well documented greater pain sensitivity in females compared with males, in all studies with vaccines which report …
Is new always better than old?: The development of human vaccines for anthrax.
Baillie LW. Baillie LW. Hum Vaccin. 2009 Dec;5(12):806-16. doi: 10.4161/hv.9777. Epub 2009 Dec 9. Hum Vaccin. 2009. PMID: 19786839 Review.
Recombinant Protective Antigen (rPA), the nontoxic cell-binding component of anthrax lethal toxin, is the principal immunogen of the vaccines currently undergoing human clinical trials. While these new vaccines are likely to show reduced side effects they wil …
Recombinant Protective Antigen (rPA), the nontoxic cell-binding component of anthrax lethal toxin, is the principal immunogen of the vacc …
Leishmaniasis.
Kedzierski L. Kedzierski L. Hum Vaccin. 2011 Nov;7(11):1204-14. doi: 10.4161/hv.7.11.17752. Epub 2011 Nov 1. Hum Vaccin. 2011. PMID: 22048116 Review.
87,166 results
You have reached the last available page of results. Please see the User Guide for more information.